AU3080692A - Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation - Google Patents

Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation

Info

Publication number
AU3080692A
AU3080692A AU30806/92A AU3080692A AU3080692A AU 3080692 A AU3080692 A AU 3080692A AU 30806/92 A AU30806/92 A AU 30806/92A AU 3080692 A AU3080692 A AU 3080692A AU 3080692 A AU3080692 A AU 3080692A
Authority
AU
Australia
Prior art keywords
derivate
slow
dihydropyridine
nanosol
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30806/92A
Inventor
Jurgen Freidenreich
Ursula Schick
Jurgen Werry
Jens-Christian Wunderlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Publication of AU3080692A publication Critical patent/AU3080692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00—Photosensitive materials
    • G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
    • G03C1/047—Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
    • G03C2001/0471—Isoelectric point of gelatine

Abstract

Slow-release medicaments containing a pharmacologically active dihydropyridine derivate as a pharmaceutically applicable nanosol have considerably improved bioavailabilities and resorption rates, with an increased tolerability of the active substances.
AU30806/92A 1991-12-05 1992-12-04 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation Abandoned AU3080692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4140194 1991-12-05
DE4140194A DE4140194C2 (en) 1991-12-05 1991-12-05 Medicament containing a dihydropyridine derivative in nanosol form and its preparation

Publications (1)

Publication Number Publication Date
AU3080692A true AU3080692A (en) 1993-06-28

Family

ID=6446394

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30806/92A Abandoned AU3080692A (en) 1991-12-05 1992-12-04 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation

Country Status (8)

Country Link
EP (1) EP0615446B1 (en)
AT (1) ATE130190T1 (en)
AU (1) AU3080692A (en)
DE (2) DE4140194C2 (en)
DK (1) DK0615446T3 (en)
ES (1) ES2082524T3 (en)
GR (1) GR3018930T3 (en)
WO (1) WO1993010770A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (en) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
DE3515335C2 (en) * 1985-04-27 1995-01-26 Bayer Ag Pharmaceutical preparation containing dihydropyridines and process for their preparation
NL194638C (en) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol.
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
EP0349428B1 (en) * 1988-06-30 1993-01-20 Centre National De La Recherche Scientifique (Cnrs) Process for preparing colloidal dispersive protein systems in the shape of nanoparticles
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form

Also Published As

Publication number Publication date
ATE130190T1 (en) 1995-12-15
DE4140194C2 (en) 1998-02-19
EP0615446A1 (en) 1994-09-21
DE4140194A1 (en) 1993-06-09
DK0615446T3 (en) 1996-02-26
EP0615446B1 (en) 1995-11-15
ES2082524T3 (en) 1996-03-16
DE59204376D1 (en) 1995-12-21
WO1993010770A1 (en) 1993-06-10
GR3018930T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
CA2240329A1 (en) Improved delivery of multiple doses of medications
CA2102630A1 (en) Pharmaceutical compositions of compacted medicaments
CA2258095A1 (en) Tetrahydrolipstatin containing compositions
CA2294783A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AU2886295A (en) Formulation for administration by inhalation
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
AU1534699A (en) Osmotic dosage form comprising first and second coats
WO1994027589A3 (en) Antidepressant dosage form
MXPA03011538A (en) Medicinal compositions.
WO2001019337A3 (en) Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
AU2084801A (en) Antiviral medication
CA2428160A1 (en) Compositions for antitumor treatment containing ecteinascidin 743
CA2360220A1 (en) Oxadiazole compounds and compositions for delivering active agents
EP0375628A3 (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
UA29435C2 (en) 3<font face="Symbol">b</font>-ALKENYLPENAM DERIVATIVES AND PHARMACEUTICALLY COMPATIBLE SALTS THEREOF
HK1023508A1 (en) Stabilized tibolone compositions.
AU1180592A (en) 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
EP0341209A3 (en) Physiologically active substances, a process for preparation and pharmaceutical compositions thereof
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU5290199A (en) Erythromycin derivatives with antibiotic activity
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
TW366284B (en) Pharmaceutical antitussive composition of delta-receptor antagonist
AU3080692A (en) Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation
GEP20043377B (en) Pharmaceutical Complex